BioSpace News Archive

University Medical Center Utrecht in the Netherlands has signed a 10-year renewal contract for digital pathology with international medical imaging IT and cybersecurity company Sectra.

Itamar Medical Ltd., a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced the appointment of Marga Ortigas-Wedekind to its Board of Directors.

Syntr Health Technologies, Inc., a medical device company specializing in the processing of autologous adipose tissue, also known as fat tissue, announced clearance from the US Food & Drug Administration for the company’s patented SyntrFuge System™ for use in surgical specialties when the transfer of harvested adipose tissue is desired.

Synlogic, Inc., a clinical stage company bringing the transformative potential of synthetic biology to medicine, reported financial results for the second quarter ended June 30, 2021, and provided an update on its clinical and preclinical programs.

Talaris Therapeutics, Inc. reported financial results for the three- and six-month periods ended June 30, 2021, and provided an update on its business.

Sio Gene Therapies Inc., a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, provided a corporate update and financial results for its fiscal first quarter ended June 30, 2021.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, reported its second quarter and year to date June 30, 2021 operating and financial results.

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system diseases, reported financial results for its fiscal quarter ended June 30, 2021.

Akouos, Inc. today reports financial results for the second quarter ended June 30, 2021 and provides business highlights.

Virios Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.